U.S. Markets closed

ARWR Jan 2021 1.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
36.850.00 (0.00%)
At close: 5:06PM EDT
Full screen
Previous Close36.85
Open37.58
Bid0.00
Ask0.00
Strike1.00
Expire Date2021-01-15
Day's Range36.85 - 36.85
Contract RangeN/A
Volume2
Open Interest199
  • Is ARWR A Good Stock To Buy Now According To Hedge Funds?
    Insider Monkey

    Is ARWR A Good Stock To Buy Now According To Hedge Funds?

    The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]

  • Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
    Business Wire

    Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

    Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

  • ARWR: Update on Cardiometabolic Candidates…
    Zacks Small Cap Research

    ARWR: Update on Cardiometabolic Candidates…

    By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Cardiometabolic Programs Offer Enormous Potential In November 2020, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) hosted KOL events for its lead cardiometabolic programs, ARO-APOC3 and ARO-ANG3. The company had previously announced encouraging results for each of those programs (see our previous update here ) and